Cartilage oligomeric matrix protein (COMP) is a protein present in the cartilage matrix and is expressed more abundantly in osteoarthritis cartilage than in healthy cartilage. The present study was designed to investigate the effect of transforming growth factor β (TGFβ) on COMP deposition and the influence of COMP on collagen biochemistry in a long-term 3-dimensional culture. Bovine chondrocytes in alginate beads were cultured with or without 25 ng/mL TGFβ2 for 21 or 35 days. COMP was overexpressed in bovine chondrocytes using lentiviral transfection. COMP gene expression, COMP protein production, collagen and proteoglycan deposition, and collagen fibril thickness were determined. Addition of TGFβ2 resulted in more COMP mRNA and protein than the control condition without growth factors. Lentiviral transduction with COMP resulted in elevated gene expression of COMP and increased COMP levels in the alginate bead and culture medium compared to untransfected cells. Overexpression of COMP did not affect the deposition of collagen, collagen cross-linking, proteoglycan deposition, or the mechanical properties. Stimulating COMP production by either TGFβ2 or lentivirus resulted in collagen fibrils with a smaller diameter. Taken together, COMP deposition can be modulated in cartilage matrix production by the addition of growth factors or by overexpression of COMP. Inducing COMP protein expression resulted in collagen fibrils with a smaller diameter. Because it has been demonstrated that the collagen fibril diameter is associated with mechanical functioning of the matrix, modulating COMP levels should be taken into account in cartilage regeneration strategies.
Oldberg A., Antonsson P., Lindblom K., Heinegard D.COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 1992;267(31):22346-50.
2.
Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., et al. Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem. 1992 ;267(9):6132-6.
3.
Smith RK, Zunino L., Webbon PM, Heinegard D.The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol . 1997;16(5):255-71.
4.
Dodge GR, Hawkins D., Boesler E., Sakai L., Jimenez SAProduction of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. Osteoarthritis Cartilage . 1998;6(6):435-40.
5.
Rosenberg K. , Olsson H., Morgelin M., Heinegard D.Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem. 1998; 273(32):20397-403.
6.
Thur J., Rosenberg K., Nitsche DP, Pihlajamaa T., Ala-Kokko L., Heinegard D., et al. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem.2001;276(9):6083-92.
7.
Mann HH, Ozbek S., Engel J., Paulsson M., Wagener R.Interactions between the cartilage oligomeric matrix protein and matrilins: implications for matrix assembly and the pathogenesis of chondrodysplasias . J Biol Chem. 2004;279(24):25294-8.
Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H., Leroy JG, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet. 1995;10(3):330-6.
10.
Hecht JT, Hayes E., Haynes R., Cole WGCOMP mutations, chondrocyte function and cartilage matrix. Matrix Biol. 2005; 23(8):525-33.
11.
Budde B., Blumbach K., Ylostalo J., Zaucke F., Ehlen HW, Wagener R., et al. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol. 2005;25(23):10465-78.
12.
Schmitz M., Becker A., Schmitz A., Weirich C., Paulsson M., Zaucke F., et al. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem. 2006;281(43):32587-95.
13.
Svensson L., Aszodi A., Heinegard D., Hunziker EB, Reinholt FP, Fassler R., et al. Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol Cell Biol. 2002; 22(12):4366-71.
14.
Halasz K., Kassner A., Morgelin M., Heinegard D.COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem. 2007;282(43):31166-73.
15.
Shen Z., Heinegard D., Sommarin Y.Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol. 1995;14(9):773-81.
16.
Koelling S. , Clauditz TS, Kaste M., Miosge N.Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res Ther. 2006;8(3):R56.
17.
Salminen H. , Perala M., Lorenzo P., Saxne T., Heinegard D., Saamanen AM, et al. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum. 2000;43(8):1742-8.
18.
Lorenzo P., Bayliss MT, Heinegard D.Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol. 2004;23(6):381-91.
19.
Recklies AD , Baillargeon L., White C.Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum. 1998;41(6):997-1006.
20.
Blaney Davidson EN, van der Kraan PM, van den Berg WBTGF-beta and osteoarthritis. Osteoarthritis Cartilage. 2007; 15(6):597-604.
21.
Bastiaansen-Jenniskens YM, Koevoet W., De Bart AC, Zuurmond AM, Bank RA, Verhaar JA, et al. TGFbeta affects collagen cross-linking independent of chondrocyte phenotype but strongly depending on physical environment . Tissue Eng Part A. 2008;14(6):1059-66.
22.
Jenniskens YM, Koevoet W., de Bart AC, Weinans H., Jahr H., Verhaar JA, et al. Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFbeta2 and FGF2. Osteoarthritis Cartilage. 2006;14(11):1136-46.
23.
Hauselmann HJ, Fernandes RJ, Mok SS, Schmid TM, Block JA, Aydelotte MB, et al. Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci. 1994;107(Pt 1):17-27.
24.
Tchetina EV , Antoniou J., Tanzer M., Zukor DJ, Poole ARTransforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production. Am J Pathol. 2006;168(1):131-40.
25.
van Susante JL, Buma P., van Beuningen HM, van den Berg WB, Veth RPResponsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J Orthop Res. 2000;18(1):68-77.
26.
van der Slot AJ, van Dura EA, de Wit EC, De Groot J., Huizinga TW, Bank RA, et al. Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta. 2005;1741(1-2):95-102.
27.
van Osch GJ , van den Berg WB, Hunziker EB, Hauselmann HJDifferential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthritis Cartilage . 1998;6(3):187-95.
28.
Enobakhare BO, Bader DL, Lee DAQuantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal Biochem.1996;243(1):189-91.
29.
Bank RA, Jansen EJ, Beekman B., te Koppele JMAmino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate . Anal Biochem. 1996;240(2):167-76.
30.
Wong M., Siegrist M., Wang X., Hunziker E.Development of mechanically stable alginate/chondrocyte constructs: effects of guluronic acid content and matrix synthesis. J Orthop Res . 2001;19(3):493-9.
31.
Bastiaansen-Jenniskens YM, Koevoet W., de Bart AC, van der Linden JC, Zuurmond AM, Weinans H., et al. Contribution of collagen network features to functional properties of engineered cartilage . Osteoarthritis Cartilage. 2008;16(3):359-66.
32.
Mow VC, Holmes MH, Lai WMFluid transport and mechanical properties of articular cartilage: a review . J Biomech. 1984;17(5):377-94.
33.
Lafeber FP, van Roy H., Wilbrink B., Huber-Bruning O., Bijlsma JWHuman osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage. J Rheumatol. 1992;19(1):123-9.
34.
Chen FH, Thomas AO, Hecht JT, Goldring MB, Lawler J.Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem . 2005;280(38):32655-61.
35.
Sharif M., Kirwan JR, Elson CJ, Granell R., Clarke S.Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum. 2004;50(8):2479-88.
36.
Wislowska M. , Jablonska B.Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis. Clin Rheumatol. 2005;24(3):278-84.
37.
Vilim V., Olejarova M., Machacek S., Gatterova J., Kraus VB, Pavelka K.Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage. 2002;10(9):707-13.
38.
Di Cesare PE, Carlson CS, Stolerman ES, Hauser N., Tulli H., Paulsson M.Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res. 1996;14(6): 946-55.
39.
Sodersten F., Ekman S., Eloranta ML, Heinegard D., Dudhia J., Hultenby K.Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon. Matrix Biol. 2005;24(5): 376-85.
40.
Bailey AJ, Paul RG, Knott L.Mechanisms of maturation and ageing of collagen. Mech Ageing Dev. 1998;106(1-2):1-56.
41.
Parry DAThe molecular and fibrillar structure of collagen and its relationship to the mechanical properties of connective tissue. Biophys Chem . 1988;29(1-2):195-209.
42.
Knight MM, van de Breevaart Bravenboer J. , Lee DA, van Osch GJ, Weinans H., Bader DLCell and nucleus deformation in compressed chondrocyte-alginate constructs: temporal changes and calculation of cell modulus. Biochim Biophys Acta. 2002;1570(1):1-8.
43.
Bastiaansen-Jenniskens YM, Koevoet W., Jansen KM, Verhaar JA, DeGroot J., VanOsch GJInhibition of glycosaminoglycan incorporation influences collagen network formation during cartilage matrix production. Biochem Biophys Res Commun.2009;379(2):222-6.
44.
Nelson F., Dahlberg L., Laverty S., Reiner A., Pidoux I., Ionescu M., et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest. 1998;102(12):2115-25.
